Companies Cryptocurrencies
Amphastar Pharmaceuticals Inc
Amphastar Pharmaceuticals Inc
Exchange: Nasdaq Global Select
IPO Date: 25/06/2014
CEO: Dr. Jack Zhang
Drug Manufacturers General Specialty & Generic Healthcare 🔗
  • AMPH
  • 35.93
  • 1754454784
    market cap
  • 0.5600014
If you bought

shares of Amphastar Pharmaceuticals Inc (AMPH) on
You would have made
Old Price $12 Current Price $12

Amphastar Pharmaceuticals, Inc. engages in the development, manufacture, market, and sale of technically challenging and proprietary injectable, inhalation, and intranasal products. The company is headquartered in Rancho Cucamonga, California and currently employs 2,078 full-time employees. The firm focuses primarily on developing, manufacturing, marketing and selling generic and injectable, inhalation and intranasal products. The firm has two segments: finished pharmaceutical products and active pharmaceutical ingredients (API) products. The finished pharmaceutical products segment manufactures, markets and distributes enoxaparin, Cortrosyn, Amphadase, naloxone, lidocaine jelly, as well as various other critical and non-critical care drugs. The API segment manufactures and distributes recombinant human insulin and porcine insulin. The firm also manufactures and sells insulin API. As of December 31, 2016, the Company manufactured and sold 19 products. As of December 31, 2016, the Company developed a portfolio of 15 generic abbreviated new drug applications (ANDAs) three generic biosimilar product candidates and six injectable and inhalation product candidates.

Address: 11570 6th St Rancho Cucamonga CALIFORNIA 91730

Stay updated.